AI in wearable sensing, home monitoring, medical imaging, genomics, biomarkers discovery, pharma, digital health, medical devices, personalized medicine, among others and leading to improved patient outcomes, health and care decision-making and efficiencies in healthcare systems.
The advent of genomics and personalized medicine has generated tremendous volumes of data at different biological scales with a need for improved decision-making to assist medical practitioners. Novel approaches using AI in drug design, enable a much faster rate of exploration and discovery of novel molecules and candidate drugs. A growing availability of multimodal digital data enable the understanding of complex relationships between genotype, phenotype, and environment through large-scale AI approaches to tease out critical relationships relative to disease. The digitalization of healthcare data in hospitals and across healthcare systems provides access to vast amounts of real-world data on health, disease, and interventions. Novel AI approaches capitalize on the pre-acquired data to significantly speedup the acquisition, reconstruction, and quantification of medical imaging data. Similarly, real world data open the opportunity to develop novel and decentralized clinical trial as well as to generate virtual populations for in silico clinical trials. However, these opportunities come with concerns about reliability and robustness, explainability, privacy, and data cybersecurity. Furthermore, many other healthcare challenges can benefit from the use of AI, including medical personnel or equipment allocation and scheduling, home monitoring and objective patient outcome monitoring in clinical trials, improved medical devices and manufacturing processes, and supply chain optimization.
Tulay Adali (University of Maryland)
Selin Aviyente (Michigan State University)
Hsun-Hsien Shane Chang (Novartis)
Gary Fogel (Natural Selection, Inc.)
Alejandro F. Frangi (University of Leeds, UK | KU Leuven, Belgium)
Mathews Jacob (University of Iowa)
Alfonso Limon (Oneirix, Inc.)
Karen Panetta (Tufts University)
Ghulam Rasool (Moffett Cancer Center)
Stephen Smith (ClearSky Medical Diagnostics, Ltd.)